MARKET WIRE NEWS
  1. Home
  2. Stock
  3. HEPA
  4. News
  5. Hepion Pharmaceuticals Appoints Kaouthar Lbiati As I
HEPA
Quote
Short
News
Articles
Message Board

Hepion Pharmaceuticals appoints Kaouthar Lbiati as interim CEO

Source: SeekingAlpha

2025-06-16 08:45:21 ET

More on ContraVir

Read the full article on Seeking Alpha

For further details see:

Hepion Pharmaceuticals appoints Kaouthar Lbiati as interim CEO
Hepion Pharmaceuticals Inc.

NASDAQ: HEPA

HEPA Trading

-21.07% G/L:

$0.318 Last:

4,368,896 Volume:

$0.385 Open:

mwn-alerts Ad 300

HEPA Latest News

March 03, 2026 07:35:00 am
Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma
August 12, 2025 07:00:56 am
Expected US Company Earnings on Tuesday, August 12th, 2025
August 12, 2025 05:31:38 am
Expected earnings - Hepion Pharmaceuticals Inc.
August 06, 2025 02:00:33 pm
PRISM Mid-Day Movers: Telehealth Turbulence and Global Health Dilution

HEPA Stock Data

$429,952
11,504,114
8.97%
17
448181%
Biotechnology & Life Sciences
Healthcare
https://www.hepionpharma.com
US
Morristown

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App